8 Hrs
Source:
عين ليبيا
Source: عين ليبيا
8 Hrsعين ليبيا
Source: عين ليبيا
8 HrsReady to play
Ready to play
The Medical Supply Authority rejected being held fully responsible for delays in supplying insulin in Libya. It explained that the process involves financial, contractual, oversight and technical stages handled by several entities, and said it had monitored needs and funding coverage and identified discrepancies in quantities. The Authority questioned why estimated needs for 2025 had been cut by 50% compared with 2024. It also raised questions about the specifications of some products, distribution mechanisms, and the link between dispensing treatment and an electronic system in which, it said, a security report had identified vulnerabilities. It called for a joint mechanism to review needs, contracts and stock levels; ensure insulin reaches emergency cases; complete funding and budget approvals; establish a safety stock; and set out each entity’s responsibilities within a clear timeline.
Notice: This Is an AI-Generated Summary
Comments (0)